拜耳携26款产品亮相第八届进博会

Group 1: Core Themes - The 8th China International Import Expo (CIIE) officially opened in Shanghai on November 5, showcasing Bayer Group's commitment to health and hunger elimination with a focus on three major divisions: prescription drugs, consumer health products, and crop science [1] - Bayer exhibited 26 highlight products, including several innovative pharmaceuticals making their debut, such as Eylea® for age-related macular degeneration and a new targeted therapy for lung cancer [1][2] Group 2: Product Highlights - Bayer's pharmaceutical innovations include the global debut of Elinzanetant, a dual neurokinin receptor antagonist for vasomotor symptoms related to menopause, and the acceptance of a new indication for Nubeqa® in metastatic hormone-sensitive prostate cancer [1] - In the consumer health segment, Bayer launched five globally debut products, addressing various health concerns such as allergies and digestive health [2] - The crop science division introduced the new crop health brand "Delaro®" along with two products, and showcased seven new corn varieties from its joint venture, Zhongzhong International [2] Group 3: Local Collaboration and Innovation - Bayer has been deepening local collaborations, including the launch of its third "Yun Yuan Farm" and the "Ling Feng Plan" to empower agricultural retailers [2] - The company is also providing digital pest control services through the "Flying General" platform and building open innovation platforms via Co.Lab and the Yizhuang Open Innovation Center [2]